Advertisement

Topics

NANOGAP Therapeutics developing 'widely applicable' cancer treatment

20:42 EST 8 Jan 2019 | Proactive Investors

NANOGAP Therapeutics CEO Ross Breckenridge joined Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.

The company is a seed level company developing therapeutics to combat a mutant gene in cancers called KRAS.

Original Article: NANOGAP Therapeutics developing 'widely applicable' cancer treatment

NEXT ARTICLE

More From BioPortfolio on "NANOGAP Therapeutics developing 'widely applicable' cancer treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...